Induction of terminal differentiation of promyelocytic HL-60 leukemic cells implanted with lymphocyte receptors and stimulated with various lymphocyte stimulators.
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology / Q000502:physiology*; D002448:Cell Adhesion; D002453:Cell Cycle; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology*; D002455:Cell Division; D002462:Cell Membrane / Q000637:transplantation*; D003208:Concanavalin A / Q000494:pharmacology; D018922:HL-60 Cells / Q000166:cytology*; D006367:HeLa Cells; D006801:Humans; D007075:Immunoglobulin M / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology; D051379:Mice; D011947:Receptors, Antigen, B-Cell / Q000187:drug effects / Q000502:physiology; D011948:Receptors, Antigen, T-Cell / Q000187:drug effects / Q000502:physiology*; D013154:Spleen / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology / Q000502:physiology*; D014212:Tretinoin / Q000494:pharmacology
D007075:Immunoglobulin M; D008070:Lipopolysaccharides; D011947:Receptors, Antigen, B-Cell; D011948:Receptors, Antigen, T-Cell; D003208:Concanavalin A; D014212:Tretinoin